In mouse insulin cells, a compound called berberine helps release more insulin by using a slow build-up of calcium and tapping into insulin stores that aren’t already lined up at the cell’s edge.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
In mouse insulin cells, a compound called berberine helps release more insulin by using a slow build-up of calcium and tapping into insulin stores that aren’t already lined up at the cell’s edge.
See the technical phrasing
In mouse pancreatic β-cells, short-term exposure to berberine under 8.3 mM glucose conditions enhances insulin exocytosis primarily by promoting the fusion of insulin granules that have not previously docked at the plasma membrane, accompanied by a gradual increase in intracellular Ca²⁺ levels during the second phase of secretion, indicating a mechanism independent of rapid calcium influx.
What the research says
Supports
1 study
Study: 1837-P: Short-Term and Long-Term Administration of Berberine Promoted Insulin Exocytosis through Different Mechanism in Pancreatic β-Cells
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies